Clinical Trial: Glecaprevir/Pibrentasvir for the Treatment of PTSD
Study Status: Completed
Recruit Status: RECRUITING
Condition: PTSD
Study Type: INTERVENTIONAL
Official Title: Glecaprevir/Pibrentasvir for the Treatment of PTSD
Brief Summary:
An open-label pilot study to further investigate glecaprevir/pibrentasvir (GLE/PIB), a direct acting antiviral (DAA) that has been associated with posttraumatic stress disorder (PTSD) symptom improvement when prescribed for the treatment of chronic hepatitis C viral infection (HCV).
Read more